We offer the most comprehensive preimplantation genetic testing (PGT) designed to identify potential health concerns in your embryos and empower you to make informed choices about your future family.
of a successful pregnancy with an informed decision.
Gattaca Genomics is dedicated to delivering exceptional care through cutting-edge technology to assist couples in realizing the aspiration of forming healthy families. Our commitment is rooted in providing unwavering support to couples, fostering an environment of compassion and comprehension. Collaborating seamlessly with esteemed In Vitro Fertilization (IVF) clinics and highly qualified medical professionals. Our unwavering dedication to ethical practices underscores our mission to empower couples on their journey towards parenthood, embodying the highest standards of reproductive healthcare.
Chief Scientific Officer
Dr. Maria Ines Mitrani, known as Dr. Mari, is a highly accomplished multilingual medical professional
with extensive expertise in biological medicine. She earned her Medical Doctor degree from the Universidad
San Francisco de Quito and pursued additional certifications from Cornell University and diverse
specialties, including Neural Therapy Philosophy from S.O.M.A.
Her career spans several impactful
roles, including serving as the Co-Founder and Chief Scientific Officer of Gattaca Genomics, and
previously held the titles of Co-Founder and Chief Science Officer at Organicell Regenerative Medicine, as
well as Co-Founder of American Stem Cell & Anti-Aging Center, a pioneer in Autologous Stem Cell
therapy worldwide.
Dr. Mari has been instrumental in developing innovative treatments for diverse
health conditions, leading to several FDA approvals for conducting various clinical trials including;
COVID-19 acute and Long Hauler sequelae, Chronic Obstructive Pulmonary Disease, and Knee
Osteoarthritis.
Dr. Mari's remarkable contributions to the battle against COVID-19 using
biologics have garnered widespread recognition, earning her a place among the 'Top 100 Healthcare
Leaders' by IFAH. Her extensive body of work includes numerous peer-reviewed publications,
presentations at prestigious conferences, all centered around the fascinating therapeutic potential of
stem cells and extracellular vesicles.
Beyond her professional endeavors, Dr. Mari is a passionate
advocate for various causes, championing women's health, minority rights, animal welfare, and
environmental sustainability. Her advocacy extends to active participation in numerous events and
conferences, reflecting her commitment to well-being.
Director of Embryology Services
Eva Schenkman, a distinguished scientist and leader in reproductive clinical laboratory science, boasts a
stellar career marked by a blend of academic prowess and practical expertise. She is a multi-talented
professional, holding an impressive array of qualifications: MS, PhD, CLT (NY), CC/ALD/ELD/HCLD
(ABB).
With a foundation rooted in Eastern Virginia Medical School, where she earned both her
Master's and Doctoral degrees, Eva has demonstrated a keen interest in investigating the effects of
environmental stress and low-oxygen environments on early embryo development. Her academic pursuits have
also delved into exploring the impact of various laboratory procedures on clinical pregnancy
rates.
Eva's professional journey showcases her unwavering dedication to elevating the
standards of clinical laboratories in the realm of assisted reproductive technologies. Her roles span
across multiple prestigious institutions and consultancies, including serving as the President of ARTLAB
Consulting. Eva is instrumental in steering high-complexity laboratory operations, directing and training
staff, overseeing IVF laboratory aspects, and ensuring adherence to stringent regulatory standards,
including those set by FDA, CAP, and CLIA. She also trains future laboratory scientists, advises MS/PhD
theses, and presents on topics ranging from environmental toxicity's effects on IVF outcomes to
quality control in the IVF laboratory.
Her prolific contributions extend to research, with Eva
having authored numerous abstracts, articles, and presentations in reputable scientific forums, shedding
light on critical facets of embryonic development and clinical outcomes. Her commitment to advancing the
field is evident through active memberships in professional societies like the American Society for
Reproductive Medicine (ASRM), American Association of Bioanalysts (AAB), and others.
Beyond her
academic and professional commitments, Eva is an advocate for ethical practices in reproductive sciences,
serving on committees and actively engaging in community outreach. Her multifaceted expertise, unwavering
commitment to scientific excellence, and dedication to education make her a leading figure in the field of
reproductive clinical laboratory science.
Laboratory Director
Amara C. Siva, Ph.D., is an accomplished laboratory operations executive with over 20 years of experience
in clinical molecular diagnostics. She's known for her strategic leadership and continuous
improvement initiatives within GxP and CLIA/CAP-regulated environments. Her expertise lies in scaling
operational capabilities, driving efficiencies, and managing clinical testing across global laboratories.
With a Ph.D. in Biological Chemistry from UCLA and a B.S. in Biochemistry & Cell Biology from UC San
Diego, Amara has a solid academic foundation complemented by certifications in Six Sigma Green Belt and
various laboratory and clinical specialties.
Amara's career spans various leadership roles,
including Senior Vice President positions at companies like Epic Sciences, Discovery Genomics,
Pathnostics, and Millennium Health. Her achievements include establishing CLIA molecular testing
laboratories, managing partner labs globally, and overseeing multimillion-dollar operational
budgets.
Her career highlights range from developing assays for cancer research to leading
high-complexity clinical trials and implementing Lean Six Sigma projects resulting in substantial cost
savings. Amara's expertise in assay development, regulatory compliance, and performance management
underscores her exceptional leadership in the clinical diagnostics domain.
Technical Supervisor
Dr. John Ramos graduated from Columbia University with a doctorate in Molecular Biochemistry and
Biophysics and Masters degrees in Physics and Biological Sciences. He also graduated from the University
of California at Los Angeles with Bachelors degrees in Neuroscience and Engineering Physics. He was a
Postdoctoral Fellow at the University of Miami Miller School of Medicine in the Department of Biophysics
and a Molecular Biologist at the University of Florida and in the U.S. Department of Agriculture,
Agricultural Research Service.Dr. Ramos’s research experience involves determining the mechanistic and
kinetic processes of ATP Binding Cassette transmembrane transporters using Fluorescence Spectroscopy,
X-Ray Crystallography, and Mass Spectroscopy. In addition, he has investigated vesicular SNARE proteins
using Atomic Force Microscopy and Confocal Microscopy. Furthermore, Dr. Ramos implemented one Agricultural
Research Station’s first Next Generation Sequencing facility for the purpose of Whole Genome
Sequencing.
During the pandemic Dr. Ramos opened one of the first Covid-19 PCR testing facilities
in the City of Hollywood Florida benefiting the local community by testing entire Fire Departments, Police
Departments and Schools.
Laboratory Operations Director
Steven M. Crespo-Carbone holds an M.S. in Microbiology and Molecular Genetics from Rutgers University and The University of Medicine and Dentistry of NJ, with research in melanoma. He is a genomics and variant interpretation curation scientist with extensive experience in pharmaceutical drug research and development, as well as in clinical genomics. He has expertise in genetic testing in reproductive health for hereditary diseases and cancer. Steven has worked at prestigious institutions such as Baylor Genetics Labs, SEMA4 Laboratories, and Bioreference Labs/GeneDx. His skills include genetic sequencing analysis and curation, molecular biology, infectious diseases, cancer biology, and genetic expression investigative toxicology. Steven has contributed to FDA clinical trials and multiple-phase antibiotic clinical trials, helping develop the molecular portion of the Idylla TM RT-PCR platform for respiratory viruses identification. He has multiple peer-reviewed manuscripts in major scientific journals where he has made significant contributions to the fields.
VP of Embryology Science Education & Business Development
Alease Daniel Barnes is an accomplished Embryologist with a strong background in Genetics. She holds a
Bachelor's degree from North Carolina State University, focusing on Genetics with a minor in
Biotechnology. Alease is an experienced professional who seamlessly integrates into fast-paced lab
environments, as demonstrated through her roles at various fertility practices. Her expertise includes
ICSI, Trophectoderm Biopsy, INVOcell, Egg Vit, and Cell Culture.
In addition to her hands-on work
in the IVF lab, Alease is a passionate educator and content creator, leveraging her extensive knowledge to
educate and advocate for fertility awareness. With a strong presence on social media platforms such as
Instagram and TikTok, she has amassed a significant following and actively strives to empower individuals
on their infertility journey by dispelling misinformation and providing support.
In her teaching
role at ARTLAB, Alease imparts her knowledge to recent undergraduate students, covering all aspects of the
IVF lab. Alease plays a key role in training Andrologists and Junior Embryologists, adhering to regulatory
guidelines. She provides hands-on training and troubleshooting for challenging skills, contributing to the
development of the next generation in the field.
As a board member for Aneden Gives, she
contributes to positive outcomes in the fertility journey, while helping to alleviate financial burdens
for families. A member of HD Reach, Alease collaborates on initiatives to support individuals with
Huntington’s Disease, utilizing her diverse background to advise on organizational goals.
A
passionate advocate and leader, Alease Daniel Barnes combines her expertise in embryology with a
commitment to education, advocacy, and community support, making significant contributions to both the
scientific and social aspects of reproductive health.
Lead Molecular Technologist
Jahmar Hudson is a highly skilled Molecular Scientist, with years of extensive experience in medical
laboratory testing. Adhering to TJC, OSHA, and FDA guidelines, Jahmar is recognized for his precision,
efficiency, and quality-focused approach. His journey began as a nursing student, where he received his
BSN shortly after graduating secondary school. Jahmar obtained his master’s in nursing from Columbia
University and a host of certificates from Yale University, with concentrations in OB/GYN and Labour and
Delivery. His desire to work in the laboratory quickly grew as he would spend majority of his shifts
assisting the scientists with blood collections and any other capacity, as long as he remained in the lab.
Jahmar’s inspiration and unquenchable thirst to further educate himself, would lead him to acquire a
Bachelor of Science in Biology from St. John’s University, a Bachelor's in Biotechnology and
Biopharmaceutical Science from Miami Dade College, Master's in Microbiology and Cell Science from the
University of Florida, currently pursing his doctoral degree in Epidemiology and Infectious Diseases at
Walden University.
Jahmar possesses a comprehensive set of skills, including molecular biology
techniques, laboratory procedures, data collection, and proficiency in technologies such as PCR, ELISA,
PGx, CGx and Next Generation Sequencing. He has played key roles in developing assays and evaluating new
technologies, showcasing his expertise in molecular and cellular research. Holding certifications like the
American Medical Technologist in Molecular Diagnostic Technologist, American Society for Clinical
Pathology in Molecular Biology, CRCST and CSPDT, and being a member of Beta Beta Beta Honor society,
National Black Nurses Association, Black Microbiologists Association and American Society for Biochemistry
and Molecular Biology. Jahmar is a qualified and committed professional.
Beyond his professional
achievements, Jahmar has showcased leadership skills as the Director of Committees for the Caribbean
Students Association and as an Associate Director at the Office of Multicultural Affairs, demonstrating
his commitment to community engagement and organizational leadership.
Director of Operations - Spain
Gustavo is a renowned leader in process optimization and the implementation of cutting-edge techniques
within diagnostic and research laboratories. His career has been marked by a commitment to efficiency,
effectiveness, and quality, driving process standardization and task automation. With over 15 years of
international experience, Gustavo has significantly contributed to the success of laboratories across
Valencia, Miami, New York, Montreal, Mexico, Istanbul, Dubai, Abu Dhabi, and Jining. He has held pivotal
roles from operational consulting to the commissioning of laboratories, ensuring comprehensive validations
and the effective training of technical teams.
As a quality specialist in genetic diagnostics and
forensic genetics, Gustavo has successfully applied international standards such as ISO 17025, CLIA, and
ISO 15189. He has also played an active role in drafting and approving technical procedures. Gustavo
possesses extensive expertise in process optimization, quality management, and the adoption of innovative
techniques in genetic diagnostics and forensic genetics. He is a respected member of The Royal Society of
Biology (UK) and a registered professional with the UK Science Council.
Additionally, he is
affiliated with the Association for the Study of Reproductive Biology (ASEBIR) and the European Society of
Human Reproduction and Embryology (ESHRE).
Chief Scientific Officer
Dr. Taylor has been an active member of the IVF community for over twenty years, showcasing his
innovative spirit and expertise. He has worked at some of the most prestigious IVF labs including
Reproductive Biology Associates in Atlanta and Main Line Fertility in Philadelphia. At Main Line Fertility
he held the position of Director of Preimplantation Genetic Testing and Oocyte Vitrification.
Under his leadership, Main Line is credited with the first live birth in the Delaware Valley from
vitrified oocytes and the pioneering live birth of an embryo screened with next-generation sequencing.
Dr. Taylor furthered his contributions through dissertation research on Preimplantation Genetics at the
University of Kent, under the guidance of Dr. Darren Griffin and Dr. Susan Gitlin, former Chief Scientific
Officer of the ASRM.
After completing his doctorate, Dr. Taylor assumed the role of laboratory
director at Reproductive Endocrinology Associates of Charlotte. Dr. Taylor is a prolific author, with
numerous scientific publications to his credit. His active involvement in professional organizations like
ASRM has earned him prestigious accolades, including the ASRM Star Award. Additionally, he was recognized
for his groundbreaking rapid warming technique which won prize paper at the PCRS meeting.
Chief Scientific Officer
Jill Chisholm A.P.N., WHNP. She obtained her B.S.N. from Georgetown University, then received her M.S.N.
from Columbia University, and graduated as a Women's Health Nurse Practitioner specializing in
genetics. Jill worked as a Nurse in infertility and reproductive endocrinology for seven years before
working as a nurse practitioner in obstetrics and gynecology for ten years. She also spent seven years in
genetic research at Rockefeller University in New York. Jill was a finalist for the Leading Women
Entrepreneurs Award in 2015 and was named Top 25 in 2016, she was nominated as Smart C.E.O. in 2017.
Jill founded GeneScreen in 2013, an independent genetic counseling company with expert genetic
counselors servicing clients in women's health, specializing in all aspects of reproductive
endocrinology. She was recently nominated in 2024 for the Ernst and Young Entrepreneur of the Year.
Lead Molecular Technologist
Gustavo is a renowned leader in process optimization and the implementation of
cutting-edge techniques within diagnostic and research laboratories. His career has been marked by a
commitment to efficiency, effectiveness, and quality, driving process standardization and task automation.
With over 15 years of international experience, Gustavo has significantly contributed to the
success of laboratories across Valencia, Miami, New York, Montreal, Mexico, Istanbul, Dubai, Abu Dhabi,
and Jining. He has held pivotal roles from operational consulting to the commissioning of laboratories,
ensuring comprehensive validations and the effective training of technical teams.
As a quality
specialist in genetic diagnostics and forensic genetics, Gustavo has successfully applied international
standards such as ISO 17025, CLIA, and ISO 15189. He has also played an active role in drafting and
approving technical procedures. Gustavo possesses extensive expertise in process optimization, quality
management, and the adoption of innovative techniques in genetic diagnostics and forensic genetics.
He is a respected member of The Royal Society of Biology (UK) and a registered professional with
the UK Science Council. Additionally, he is affiliated with the Association for the Study of Reproductive
Biology (ASEBIR) and the European Society of Human Reproduction and Embryology (ESHRE).
Lead Molecular Technologist
Keirshea “Kay” Smith is a proficient Technical Supervisor specializing in
high-complexity molecular biology testing, currently excelling at several distinguished laboratories. In
her role, Kay supervises operations and oversees various molecular laboratory tests, including respiratory
viral panels and genetic testing, demonstrating exceptional leadership and management skills.
Kay
has a strong foundation in laboratory procedures and compliance standards from her experience as a
Molecular Technologist/Medical Technologist at Memorial Regional Hospital South. Her education at Florida
National University and the University of Florida further solidified her expertise and commitment to
quality. Throughout her career, Kay has been commended for her attention to detail and intensive
collaboration with healthcare professionals.
Her passion for continuous improvement and
problem-solving makes her a valuable asset in the field of clinical research.
Lead Molecular Technologist
Adam Goodman is a clinical molecular geneticist and experienced entrepreneur in the
field of preimplantation genetics. After graduating from University of Michigan, he trained for many years
at theReproductive Genetics Institute in Chicago, under Yuri Verlinsky and Svetlana Rechitsky, two
founding pioneers in the field of preimplantation genetics. There he helped the lab become one of the
first in the world to utilize NGS technology for the detection of aneuploidy in human embryos.
Adam has successfully founded PGT programs for several laboratories across the United States,
playing an essential role in the adoption of evolving technologies, and helping them to stay at the
forefront of preimplantation genetic testing. He has worked in the field for over 15yrs and has an
unrivaled level of technical expertise as it pertains to the development of reliable, accurate, and
efficient assays for the assessment of human embryonic health.
He has helped author multiple
publications and has presented his research at several of the most renowned professional organizations,
such as ASRM, MRS, PCRS, and PGDIS.
Lead Molecular Technologist
Albert Mitrani is a veteran with 18 years of experience in the biotechnology and regenerative medicine
industry. As the Chief Operating Officer at Gattaca Genomics, Albert oversees the operations, strategy,
and growth of the leading embryonic genetic testing company.
Prior to joining Gattaca, Albert was
the COO at Oranicell Regenerative Medicine in Miami. He also co-founded Analytical Stem Cell, Ecuador’s
first autologous stem cell center, where he worked directly with the Ecuadorian government to write new
laws for research and treatment using autologous stem cells. He was instrumental in Analytical Stem Cell’s
opening of additional stem cell clinics in Guatemala, Trinidad, Tobago, and Jamaica.
Driven by a
passion for advancing the field of genetics through positive impact and value, Albert brings to the table
a diversity of perspectives and experiences to the team, having worked in various countries with different
cultures.
Lead Molecular Technologist
With over 40 years of experience in Finance and Administration, Philip Louie is a seasoned professional
who brings a wealth of expertise across diverse sectors. His solid foundation of twelve years in public
companies equip him with the expertise to navigate the complexities of the ever-evolving entrepreneurial
landscape.
Philip’s plethora of experience prior to joining Gattaca includes founding Louie &
Associates Management Consultants, where he played a pivotal role in shaping financial strategies for
various entities. He was also Chief Financial Officer at Nicer Canada Corp., where he engaged with brokers
to secure financing.
Beyond his extensive corporate roles, Philip has a rich history of leadership
as the President of ACFC, the Treasurer and Finance Department Head for the National Film Union of Film
and Craftspeople, where he coordinated contract negotiations with American Film Producers.
As a
Notary Public, CPA (formerly Chartered Accountant), and Certified Management Accountant, Philip’s
experience is built on a solid educational foundation with a commitment to academic excellence.
Lead Molecular Technologist
Michael Carbonara is a seasoned business leader renowned for his transformative leadership in the
financial and technology sectors. As the CEO of Gattaca Genomics, Michael leads a team of distinguished
scientists and doctors to integrate AI technologies into genomics diagnostics and
research.
Michael’s strategic vision and adept management of revenue models have been paramount in
driving the Gattaca Genomics’ mission forward, bringing the company to the forefront of genomic science.
In tandem with his role at Gattaca Genomics, Michael also serves as the CEO of Ibanera, where he
navigates complex regulatory environments, spearheads financial technology innovations, and foresters
global business development strategies.Beyond his executive roles, Michael also contributed his leadership
as a board member for Organicell Regenerative Medicine, Inc., overseeing critical functions for public
companies and playing a pivotal role in regulatory compliance and strategic
decision-making.
Michael Carbonara continues his contribution to the future of genomics and fintech
industries with a commitment to innovation and excellence, driving meaningful advancements in healthcare
and financial services.
Lead Molecular Technologist
As a seasoned advisor in the healthcare industry, Shawn Vincent is known throughout the market for
delivering and sustaining revenues by collaborating with an established network for 20 years in
pharmaceutical, genetic testing and healthcare, with a particular emphasis on "big data"
analytics. He has excelled in leadership positions for large pharmaceutical & biotech companies such
as Pfizer, PerkinElmer, California Cryobank & Sema4, where he demonstrated the ability to ramp quickly
by identifying opportunities to optimize sales growth and succeed in industry adjacencies.
Shawn
joined Gattaca Genomics to lead the development and execution of comprehensive strategic plans to drive
growth, optimize operations, and capitalize on emerging trends while remaining dedicated to advancing
precision medicine with a profound commitment to ensuring optimal patient care.
